Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.

NCT05145348 · clinicaltrials.gov ↗

UNKNOWN

Status

640

Enrollment

OTHER

Sponsor class

Conditions

Down Syndrome
SARS-CoV-2 Vaccination

Interventions

BIOLOGICAL: Immune response to Sars-CoV-2 vaccinations; including COVID-19 vaccin Moderna, Comirnaty (Pfizer) and Vaxzevria (AstraZeneca)

Sponsor

UMC Utrecht

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]